ARCC stock results show that Ares Capital missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. More
Articles
GTHX Stock Earnings: G1 Therapeutics Beats EPS, Misses Revenue for Q1 2024
GTHX stock results show that G1 Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. More
WLK Stock Earnings: Westlake Beats EPS, Beats Revenue for Q1 2024
WLK stock results show that Westlake beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More
WLKP Stock Earnings: Westlake Chemical Misses EPS, Beats Revenue for Q1 2024
WLKP stock results show that Westlake Chemical missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. More
UTHR Stock Earnings: United Therapeutics Beats EPS, Beats Revenue for Q1 2024
UTHR stock results show that United Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More
COR Stock Earnings: Cencora Beats EPS, Misses Revenue for Q2 2024
COR stock results show that Cencora beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. More
TECH Stock Earnings: Bio-Techne Beats EPS, Beats Revenue for Q3 2024
TECH stock results show that Bio-Techne beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024. More
